Skip to main content
Top
Published in: Cardiovascular Intervention and Therapeutics 2/2018

01-04-2018 | Images in Cardiovascular Intervention

Early disarticulation of a bioresorbable vascular scaffold: an underreported consequence of repeat imaging

Authors: Joel P. Giblett, Adam J. Brown, Stephen P. Hoole, Nick E. J. West

Published in: Cardiovascular Intervention and Therapeutics | Issue 2/2018

Login to get access

Excerpt

A 54 year-old male presented with a non ST-elevation myocardial infarction. Coronary angiography revealed significant stenoses in the proximal left anterior descending (LAD) and circumflex arteries. The LAD lesion had only mild calcification and was not tortuous. It was 1:1 (balloon:vessel) pre-dilated and a 3.5 × 18 mm absorb bioresorbable vascular scaffold (BVS, Abbott Vascular, USA) was deployed at 14 atmospheres and optimized with a 4.0 × 12 mm non-compliant balloon to 10 atmospheres. Post-deployment optical coherence tomography (OCT, Dragonfly C7XR, St. Jude Medical, USA) showed a well-expanded and apposed scaffold with no evidence of scaffold strut fracture (Fig. 1a and Supplementary Video). The patient was discharged with the intention of staged PCI to the circumflex. Following successful FFR-guided PCI to the circumflex 58 days later, OCT reimaging of the LAD demonstrated disarticulation of a distal portion of the BVS (Fig. 1b and Supplementary Video). The distal portion of the BVS was 4.1 mm distal to the main body of the scaffold.
Appendix
Available only for authorised users
Literature
1.
go back to reference Serruys PW, Onuma Y, Ormiston JA, de Bruyne B, Regar E, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation. 2010;122(22):2301–12.CrossRefPubMed Serruys PW, Onuma Y, Ormiston JA, de Bruyne B, Regar E, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation. 2010;122(22):2301–12.CrossRefPubMed
2.
go back to reference Nakazawa G, Finn AV, Vorpahl M, Ladich E, Kutys R, Balazs I, Kolodgie FD, Virmani R. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol. 2009;54(21):1924–31.CrossRefPubMed Nakazawa G, Finn AV, Vorpahl M, Ladich E, Kutys R, Balazs I, Kolodgie FD, Virmani R. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol. 2009;54(21):1924–31.CrossRefPubMed
Metadata
Title
Early disarticulation of a bioresorbable vascular scaffold: an underreported consequence of repeat imaging
Authors
Joel P. Giblett
Adam J. Brown
Stephen P. Hoole
Nick E. J. West
Publication date
01-04-2018
Publisher
Springer Japan
Published in
Cardiovascular Intervention and Therapeutics / Issue 2/2018
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-017-0464-y

Other articles of this Issue 2/2018

Cardiovascular Intervention and Therapeutics 2/2018 Go to the issue